Skip to main content
$0.056 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
14 November 2026 at 6:49pm
If you were already registered, log in here.

Short Interest

ASIC data, 8 Dec 2017

% Shorted

0.02%
vs 0.02% prior report

Most Shorted Rank

428th
of 711 shorted ASX stocks

Peak Short

0.09%
Dec 2016

Days to Cover

0.1
at 50d avg vol
Subject
CDY Ann: Results of Meeting

CDY Ann: AGM Presentation to Shareholders

CDY Ann: Release of Shares from Voluntary Escrow

CDY Ann: Cellmid receives R&D tax credit

CDY Ann: Proposed issue of securities - CDY

CDY Ann: Letter to Shareholders - Notice of Annual General Meeting

CDY Ann: Notice of Annual General Meeting/Proxy Form

CDY Ann: Jobkeeper Payments Notification

CDY Ann: Initial Director's Interest Notice - Christopher

CDY Ann: Final Director's Interest Notice - Eck-Thompson

CDY Ann: Becoming a substantial holder from HNG

CDY Ann: Appointment of Non-Executive Director

CDY Ann: Cleansing Notice

CDY Ann: Application for quotation of securities - CDY

CDY Ann: BLC Cosmetics Acquisition Completed

CDY Ann: Results of Meeting

CDY Ann: General Meeting Presentation

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Notification of cessation of securities - CDY

CDY Ann: Investor Webinar

CDY Ann: Change of Director's Interest Notice - Halasz

CDY Ann: Letter to Shareholders - Notice of General Meeting

CDY Ann: Notice of General Meeting/Proxy Form

CDY Ann: Appendix 4G and Corporate Governance Statement

CDY Ann: Annual Report to shareholders

CDY Ann: HNG: BLC Cosmetics to merge with Cellmid

CDY Ann: Proposed issue of securities - CDY

CDY Ann: Cellmid to Acquire BLC Cosmetics Pty Ltd

CDY Ann: Appendix 4E and FY21 Financial Report

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Notification of cessation of securities - CDY

CDY Ann: MarketLit Investor Conference Presentation

CDY Ann: Cellmid Reports Record QVC Sales

CDY Ann: Release of Shares from Voluntary Escrow

CDY Ann: FGF5 Inhibitors Supply Agreement - Additional Information

CDY Ann: Supply Agreement for Cellmid's FGF5 Inhibitors

CDY Ann: Investor Briefing and Presentation

CDY Ann: Chinese Import Permits Received

CDY Ann: Investor Briefing

CDY Ann: Agreement Signed for Sale of Lyramid Limited

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Change of Director's Interest Notice - Eck

CDY Ann: Change of Director's Interest Notice - Cross

CDY Ann: Change of Director's Interest Notice - Halasz

CDY Ann: Change of Director's Interest Notice - Gordon

CDY Ann: CDYOA Top20 and Distribution List

CDY Ann: Appendix 2A

CDY Ann: Supplementary Prospectus

CDY Ann: Proposed issue of Securities - CDY

CDY Ann: Rights Issue Closed with Strong Demand

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX
S88
MAV
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS
MBM